These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10808806)

  • 21. [Angioplasty or fibrinolytic therapy in acute myocardial infarction with ST elevation?].
    Vik-Mo H
    Tidsskr Nor Laegeforen; 2004 Mar; 124(5):648-51. PubMed ID: 15004611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life of elderly patients after prehospital thrombolytic therapy.
    Väisänen O; Mäkijärvi M; Silfvast T
    Resuscitation; 2005 Aug; 66(2):183-8. PubMed ID: 15955612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antithrombotic therapy of acute coronary syndromes].
    Hölschermann H
    Hamostaseologie; 2007 Dec; 27(5):319-25; quiz 326-7. PubMed ID: 18060240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute coronary syndrome (without ST-elevation)].
    Rupprecht HJ; Genth-Zotz S; Jungmair W; Espinola-Klein C; Blankenberg S; Post F
    Z Kardiol; 2004; 93 Suppl 4():IV1-8. PubMed ID: 15085360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI).
    Sayah AJ; Roe MT
    J Emerg Med; 2008 May; 34(4):405-16. PubMed ID: 18164167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolytic therapy in acute myocardial infarction: time to treatment in Canada.
    Davies C; Christenson J; Campbell A; Cox JL; Huynh T; Matheson S; Daly PA; Hilbe J;
    Can J Cardiol; 2004 Jun; 20(8):801-5. PubMed ID: 15229762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
    Kalus JS; Moser LR
    Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolytic therapy for acute myocardial infarction.
    Meister FL; Stringer KA; Spinler SA; Gonzalez E; Talbert RL; Weiner B; Guerrero RM; Smith R
    Pharmacotherapy; 1998; 18(4):686-98. PubMed ID: 9692643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic trends in myocardial infarct. Preliminary data on long-term treatment with fibrinolytic agents in angiopathic patients].
    Molino N
    Cardiol Prat; 1967 Oct; 18(5):51-7. PubMed ID: 4179097
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for general practitioners administering thrombolytics.
    Rawles J
    Drugs; 1995 Oct; 50(4):615-25. PubMed ID: 8536550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data].
    Goldman L
    Recenti Prog Med; 1980 Apr; 68(4):382-93. PubMed ID: 6992245
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticoagulants and fibrinolytics in myocardial infarct].
    Messini M
    Clin Ter; 1967 Aug; 42(4):299-314. PubMed ID: 5608821
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in the medical management of acute coronary syndromes.
    Cannon CP
    J Thromb Thrombolysis; 1999 Apr; 7(2):171-89. PubMed ID: 10364769
    [No Abstract]   [Full Text] [Related]  

  • 39. [The current achievements and problems of thrombolytic therapy].
    Bokarev IN
    Ter Arkh; 1992; 64(10):101-5. PubMed ID: 1485236
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of myocardial infarction.
    Gershlick AH; More RS
    BMJ; 1998 Jan; 316(7127):280-4. PubMed ID: 9472514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.